Protecting islet functional viability using mesenchymal stromal cells

Area of Science:

• * Regenerative Medicine
• * Cell Biology
• * Immunology

Background:

• * Islet transplantation is a promising treatment for type 1 diabetes, aiming for physiological glucose control.
• * Current protocols face challenges due to rapid decline in islet viability caused by hypoxia and cytokine stress.
• * Mesenchymal stromal cells (MSCs) show potential in improving islet survival and function.

Purpose of the Study:

• * To review recent studies on MSCs protecting pancreatic islets from hypoxia and cytokine-induced stress.
• * To elucidate the mechanisms by which MSCs enhance islet functional viability.
• * To explore MSC-based strategies for improving islet transplantation outcomes.

Main Methods:

• * Review of in vitro studies examining islet responses to hypoxia and inflammatory cytokines.
• * Analysis of coculture and cotransplantation models involving islets and MSCs.
• * Investigation of MSC-secreted factors and potential mitochondrial transfer mechanisms.

Main Results:

• * MSCs protect islets from apoptosis and loss of glucose-stimulated insulin secretion under hypoxic and cytokine stress.
• * Protective effects are mediated primarily by secreted factors from MSCs.
• * MSCs may transfer functional mitochondria to stressed beta cells, supporting their function.

Conclusions:

• * MSCs offer significant protection to pancreatic islets against common transplantation stressors.
• * Understanding MSC-mediated protection mechanisms can lead to novel cell-free therapeutic strategies.
• * MSC secretome-based approaches hold promise for enhancing islet graft function in type 1 diabetes treatment.